Nan Fung Trinity’s Cidara Therapeutics CDTX Stock Holding History

Nan Fung Trinity’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-77,100	Closed	-$17M	–	70
2025 Q4	$17M	Buy	+77,100	New	+$12.5M	1.35%	28

Nan Fung Trinity's CDTX Position: Q1 2026 in Review

Nan Fung Trinity sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 77,100 shares — an estimated $17M sold.

Nan Fung Trinity first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $17M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Nan Fung Trinity reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Nan Fung Trinity sold 77,100 Cidara Therapeutics shares in Q1 2026, an estimated $17M.
Nan Fung Trinity first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Nan Fung Trinity's Cidara Therapeutics position peaked at $17M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Nan Fung Trinity's 13F filing for Q1 2026, filed 5 May 2026.